Like a dating ritual where the perused finally signals to the pursuer it’s time for the payoff, Allergan, Inc. (NYSE:AGN) is formally sending signals to Bill Ackman and Valeant Pharmaceuticals Intl Inc (NYSE:VRX) (TSE:VRX) that time for action is upon us. Allergan ready to select the one After nearly an eight month courtship, an Allergan spokesperson today signaled the biotech firm is ready to select “the one,” a long term partner to merge with. “The Board remains focused on a single commitment, enhancing value for all of Allergan, Inc. (NYSE:AGN)’s stockholders,” an Allergan spokesperson said in a statement sent to ValueWalk. In…
Allergan Signals Its Ready To Talk to Valeant
Mark Melin
Mark Melin is an alternative investment practitioner whose specialty is recognizing the impact of beta market environment on a technical trading strategy. A portfolio and industry consultant, wrote or edited three books including High Performance Managed Futures (Wiley 2010) and The Chicago Board of Trade’s Handbook of Futures and Options (McGraw-Hill 2008) and taught a course at Northwestern University's executive education program.
Comments are closed.